Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3417690 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL687164 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL688371 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL876183 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL8971411 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL8397872 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL632849 | 1.00 | — | — | |
| SCHEMBL8971174 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL20952537 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR | |
| SCHEMBL688420 | 1.00 | LCK (0.52) | LCKPPARDZDHHC20ZDHHC2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2538947-A1 | POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS | Relypsa, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| WO-2011106545-A1 | POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS | RELYPSA, INC. (US) | 2011-09-01 | — | — | WO | claimed |
| EP-4267671-A1 | COMPOSITIONS FOR ELASTOMERIC COMPOUNDS AND TYRES FOR VEHICLES COMPRISING REVERSIBLE CROSS-LINKING AGENT | Pirelli Tyre S.p.A. (IT) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022137099-A1 | COMPOSITIONS FOR ELASTOMERIC COMPOUNDS AND TYRES FOR VEHICLES COMPRISING REVERSIBLE CROSS-LINKING AGENT | PIRELLI TYRE S.P.A. (IT) | 2022-06-30 | — | — | WO | disclosed |
| EP-3362439-A1 | BIOMASS-DERIVED POLYMERS AND COPOLYMERS INCORPORATING MONOLIGNOLS AND THEIR DERIVATIVES | The Regents of the University of California (US) | 2018-08-22 | — | — | EP | disclosed |
| WO-2018134344-A1 | ZWITTERIONIC NANOPARTICLES | FRAUNHOFER-INSTITUT FÜR ANGEWANDTE POLYMERFOSCHUNG IAP (DE) | 2018-07-26 | — | — | WO | disclosed |
| WO-2017066699-A1 | BIOMASS-DERIVED POLYMERS AND COPOLYMERS INCORPORATING MONOLIGNOLS AND THEIR DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-04-20 | — | — | WO | disclosed |
| EP-3145984-A1 | THERAPEUTIC CONJUGATES WITH SULFATED DENDRIMERS FOR INTRACELLULAR TARGETING | IC Discovery GmbH (DE) | 2017-03-29 | — | — | EP | disclosed |
| WO-2016025536-A1 | THERMAL ENERGY STORAGE PHASE CHANGE MATERIALS COMPRISING BORONIC ACIDS AND METHODS OF MAKING AND USING THEM | ENTROPY SOLUTIONS INC. (US) | 2016-02-18 | — | — | WO | disclosed |
| WO-2015177279-A1 | THERAPEUTIC CONJUGATES WITH SULFATED DENDRIMERS FOR INTRACELLULAR TARGETING | IC DISCOVERY GMBH (DE) | 2015-11-26 | — | — | WO | disclosed |
| US-8623897-B2 | Methods and compositions for treatment of diabetes and dyslipidemia | KAREUS THERAPEUTICS, SA (CH) | 2014-01-07 | — | — | US | disclosed |
| EP-1086066-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | Advanced Medicine, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-1083918-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE 5-HT RECEPTORS | Advanced Medicine, Inc. (US) | 2001-03-21 | — | — | EP | disclosed |
| EP-1060226-A1 | LIQUID CRYSTAL POLYMER DEVICES AND MATERIALS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-12-20 | — | — | EP | disclosed |
| EP-1032825-A1 | IMPROVEMENTS IN OR RELATING TO ELECTROCHEMICAL ASSAYS | UNILEVER PLC (GB) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999064043-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999064044-A1 | NOVEL THERAPEUTIC AGENTS THAT MODULATE 5-HT RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999043763-A1 | LIQUID CRYSTAL POLYMER DEVICES AND MATERIALS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1999-09-02 | — | — | WO | disclosed |
| WO-1999027356-A1 | IMPROVEMENTS IN OR RELATING TO ELECTROCHEMICAL ASSAYS | UNILEVER PLC (GB) | 1999-06-03 | — | — | WO | disclosed |
| US-5858634-A | MECHANICALLY FORMING VERY SMALL DROPLETS OF UNSATURATED MONOMER; POLYMERIZING; COATING WITH BINDER; DRYING | EASTMAN KODAK COMPANY (US) | 1999-01-12 | — | — | US | disclosed |